Risk of hypogammaglobulinemia, infections with rituximab increased in pediatric patients
Pediatric News ,
A quarter of children receiving treatment with rituximab developed hypogammaglobulinemia within 18 months of starting the drug…
A quarter of children receiving treatment with rituximab developed hypogammaglobulinemia within 18 months of starting the drug…
Despite the increased use of rituximab in treating pediatric patients with autoimmune diseases in the last decade, there are…